Imperva Inc (NYSE:IMPV) has been given a $58.00 target price by analysts at Piper Jaffray Companies in a research note issued on Monday. The firm presently has a “buy” rating on the software maker’s stock. Piper Jaffray Companies’ target price would indicate a potential upside of 33.33% from the stock’s previous close.

Other analysts also recently issued reports about the stock. BidaskClub downgraded shares of Imperva from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 5th. Evercore ISI restated a “buy” rating and set a $56.00 target price on shares of Imperva in a report on Monday, May 15th. Monness Crespi & Hardt raised their target price on shares of Imperva from $52.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, May 5th. TheStreet upgraded shares of Imperva from a “d” rating to a “c” rating in a report on Thursday, May 4th. Finally, Stifel Nicolaus restated a “hold” rating and set a $47.00 target price on shares of Imperva in a report on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $51.61.

Imperva (IMPV) opened at 43.50 on Monday. The stock’s 50 day moving average is $46.50 and its 200-day moving average is $45.52. Imperva has a 52 week low of $34.40 and a 52 week high of $57.24. The stock’s market capitalization is $1.47 billion.

Imperva (NYSE:IMPV) last announced its earnings results on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.05 by $0.15. The company had revenue of $74.44 million for the quarter, compared to analyst estimates of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The business’s quarterly revenue was up 28.6% on a year-over-year basis. During the same quarter last year, the business posted ($0.23) earnings per share. Equities research analysts forecast that Imperva will post $0.81 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Imperva Inc (IMPV) PT Set at $58.00 by Piper Jaffray Companies” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/30/imperva-inc-impv-pt-set-at-58-00-by-piper-jaffray-companies.html.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 2.20% of the company’s stock.

Several large investors have recently made changes to their positions in IMPV. Ameritas Investment Partners Inc. acquired a new stake in shares of Imperva during the first quarter worth about $102,000. KCG Holdings Inc. acquired a new stake in shares of Imperva during the first quarter worth about $201,000. Migdal Insurance & Financial Holdings Ltd. boosted its stake in shares of Imperva by 26.2% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after buying an additional 866 shares during the last quarter. Amalgamated Bank acquired a new stake in shares of Imperva during the second quarter worth about $206,000. Finally, US Bancorp DE boosted its stake in shares of Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after buying an additional 3,163 shares during the last quarter. 92.72% of the stock is owned by institutional investors.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Stock Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related stocks with our FREE daily email newsletter.